10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001121781-16-000472`
Period End Date	20160331
Filing Date	20160519
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	gthp-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 42 Cash Flow Statement 56

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$95.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$75.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $75 and $95 at March 31, 2016 and December 31, 2015, respectively	`AccountsReceivableNet`	$190.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $75 and $95 at March 31, 2016 and December 31, 2015, respectively	`AccountsReceivableNet`	$230.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$118.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$156.00K	USD	Point-in-time
Inventory, net of reserves of $156 and $118, at March 31, 2016 and December 31, 2015, respectively	`InventoryNet`	$1.25M	USD	Point-in-time
Inventory, net of reserves of $156 and $118, at March 31, 2016 and December 31, 2015, respectively	`InventoryNet`	$1.12M	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssets`	$780.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssets`	$509.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12M	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	5.60	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	5.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$264.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$318.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$54.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$121.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	5.00	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	5.60	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$439.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$4.97K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$318.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$5.55K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.37M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.56M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	2,371.00	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$259.00K	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	5,322.00	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$752.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	5,322.00	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$590.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	2,371.00	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$133.00K	USD	Point-in-time
Convertible note current portion	`ConvertibleNotesPayableCurrent`	$479.00K	USD	Point-in-time
Convertible note current portion	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$686.00K	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$591.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.98M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.82M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.91M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.07M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$217.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$66.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.03M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.52M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.61M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.59M	USD	Point-in-time
Long-term convertible notes payable, net	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Long-term convertible notes payable, net	`ConvertibleLongTermNotesPayable`	$197.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.61M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.78M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.82M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$8.12M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.0 and 5.6 shares issued and outstanding as of March 31, 2016 and December 31, 2015, (Liquidation preference of $4,966 and $5,555 at March 31, 2016 and December 31, 2015)	`SeriesCPreferredStock`	$2.05M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.0 and 5.6 shares issued and outstanding as of March 31, 2016 and December 31, 2015, (Liquidation preference of $4,966 and $5,555 at March 31, 2016 and December 31, 2015)	`SeriesCPreferredStock`	$1.82M	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 5,322 and 2,371 shares issued and outstanding as of March, 31 2016 and December 31, 2015	`CommonStockValue`	$236.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 5,322 and 2,371 shares issued and outstanding as of March, 31 2016 and December 31, 2015	`CommonStockValue`	$297.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$115.47M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$114.84M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.90M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.45M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.56M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.37M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.56M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$127.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$262.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$68.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$107.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$194.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$20.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$373.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$290.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$117.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$172.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$917.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$963.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.32M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.49M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Other income	`OtherIncome`	$21.00K	USD	1 Quarter
Other income	`OtherIncome`	$23.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$158.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$492.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$714.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.40M	USD	1 Quarter
Total other income	`OtherNonoperatingIncome`	$1.26M	USD	1 Quarter
Total other income	`OtherNonoperatingIncome`	$243.00K	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$130.00K	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.25M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-1.25M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$130.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-470.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-31.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-340.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.28M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-1.31	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-0.11	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	$-1.31	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	-	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	973.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	3,084.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	973.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	109,899.00	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-1.25M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$130.00K	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	$17.00K	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	-	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$72.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$54.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$402.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$54.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$30.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$192.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$714.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$1.40M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$135.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$20.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$56.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-31.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-47.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-271.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-18.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-8.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$153.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-169.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-151.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$508.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$55.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$262.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$619.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-1.08M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-955.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-626.00K	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$451.00K	USD	1 Quarter
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.03M	USD	1 Quarter
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$62.00K	USD	1 Quarter
Payments on notes payable	`PaymentsOfLoanCosts`	$53.00K	USD	1 Quarter
Payments on notes payable	`PaymentsOfLoanCosts`	$31.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$482.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$976.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-144.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$1.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$22.00K	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$125.00K	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$50.00K	USD	1 Quarter
Dividends on preferred stock	`DividendsOnPreferredStock`	$470.00K	USD	1 Quarter
Dividends on preferred stock	`DividendsOnPreferredStock`	$31.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.